Skip to content
#

ai-drug-discovery

Here are 8 public repositories matching this topic...

Language: All
Filter by language

A bilingual work-in-progress book on AI-driven phenotypic drug discovery, from high-throughput screening and Cell Painting to machine learning and drug development.

  • Updated Jul 20, 2026

Iambic Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Iambic Therapeutics is a San Diego, California AI-driven drug discovery company founded in 2019 by Thomas Miller (CEO) and Fred Manby (CTO) that designs small-molecule therapeutics for oncology and other indications.

  • Updated Sep 4, 2026

XtalPi — independent third-party profile of a public API surface, by API Evangelist. XtalPi is an AI-and-quantum-physics drug discovery and materials research platform company with headquarters in Cambridge, Massachusetts and major operations in Beijing, Shanghai, and Shenzhen, publicly listed on the Hong Kong Stock Exchange under stock code 2228.H

  • Updated Sep 4, 2026

Add this topic to your repo

To associate your repository with the ai-drug-discovery topic, visit your repo's landing page and select "manage topics."

Learn more